Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Dorota Lubgan"'
Autor:
Kristin Schink, Hans J. Herrmann, Raphaela Schwappacher, Julia Meyer, Till Orlemann, Elisabeth Waldmann, Bernd Wullich, Andreas Kahlmeyer, Rainer Fietkau, Dorota Lubgan, Matthias W. Beckmann, Carolin Hack, Wolfgang Kemmler, Jürgen Siebler, Markus F. Neurath, Yurdagül Zopf
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-17 (2018)
Abstract Background Physical exercise and nutritional treatment are promising measures to prevent muscle wasting that is frequently observed in advanced-stage cancer patients. However, conventional exercise is not always suitable for these patients d
Externí odkaz:
https://doaj.org/article/422d9af3a49540d4b881fca3e48df53c
Autor:
Andre Karius, Michael Lotter, Stephan Kreppner, Verena Schaller, Dorota Lubgan, Johanna Grigo, Rainer Fietkau, Vratislav Strnad, Christoph Bert
Publikováno v:
Brachytherapy. 21:635-646
Seed brachytherapy is a well-established treatment modality for prostate cancer. However, there is still a lack of profound characterizations of seed motions within the prostate. We assessed these dynamics between day 0 and day 30 of brachytherapy.We
Autor:
Stephanie E. Combs, Andreas Sauter, Michal Devecka, Bernhard Haller, Hanno Specht, Michael Molls, Thomas Duell, Hubert Hautmann, Rudolf Huber, Dorota Lubgan, Rainer Fietkau, Claus Rödel, Matthias Hautmann, Konrad Kokowski, Norbert Ahrens, Robert Offner, Martin Hildebrandt, Christiane Blankenstein, A. Graham Pockley, Caroline Werner, Maxim Shevtsov, Wolfgang Sievert, Stefan Stangl, Sophie Seier, Gabriele Multhoff
Supplemetary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6096135ebff975e56abb115589775700
https://doi.org/10.1158/1078-0432.22476339.v1
https://doi.org/10.1158/1078-0432.22476339.v1
Autor:
Stephanie E. Combs, Andreas Sauter, Michal Devecka, Bernhard Haller, Hanno Specht, Michael Molls, Thomas Duell, Hubert Hautmann, Rudolf Huber, Dorota Lubgan, Rainer Fietkau, Claus Rödel, Matthias Hautmann, Konrad Kokowski, Norbert Ahrens, Robert Offner, Martin Hildebrandt, Christiane Blankenstein, A. Graham Pockley, Caroline Werner, Maxim Shevtsov, Wolfgang Sievert, Stefan Stangl, Sophie Seier, Gabriele Multhoff
Purpose:Non–small cell lung cancer (NSCLC) is a fatal disease with poor prognosis. A membrane-bound form of Hsp70 (mHsp70) which is selectively expressed on high-risk tumors serves as a target for mHsp70-targeting natural killer (NK) cells. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8285b62d1cc0f7b87499419a0eff3e51
https://doi.org/10.1158/1078-0432.c.6529371.v1
https://doi.org/10.1158/1078-0432.c.6529371.v1
Autor:
Anastazja Poczta, Piotr Krzeczyński, Maksim Ionov, Aneta Rogalska, Udo S. Gaipl, Agnieszka Marczak, Dorota Lubgan
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14258
Myeloablative therapy with highdoses of the cytostatic drug melphalan (MEL) in preparation for hematopoietic cell transplantation is the standard of care for multiple myeloma (MM) patients. Melphalan is a bifunctional alkylating agent that covalently
Publikováno v:
Strahlentherapie Und Onkologie
Purpose The aim of this study was to evaluate the safety and long-term tumor control after stereotactic radiotherapy (SRT) with 12 × 6 Gy of patients with primary bronchial carcinoma (BC) or with pulmonary metastases (MET) of various solid tumors. L
Autor:
Uwe A. Wittel, A Pirkl, Werner Hohenberger, Stefan Boeck, Ulf P. Neumann, Helmut Oettle, Anke Reinacher-Schick, Roland S. Croner, L. Jacobasch, Sabine Semrau, Henriette Golcher, Ludwig Keilholz, Rainer Fietkau, Robert Grützmann, Michael Ghadimi, Waldemar Uhl, Sandra Rutzner, Werner Adler, Wolf O. Bechstein, D. Imhoff, Dorota Lubgan
Publikováno v:
Strahlentherapie Und Onkologie
Purpose Chemotherapy with or without radiotherapy is the standard in patients with initially nonmetastatic unresectable pancreatic cancer. Additional surgery is in discussion. The CONKO-007 multicenter randomized trial examines the value of radiother
Autor:
Olaf Gefeller, Peter Breinl, Christian Rübe, Attila Salay, Oliver Kölbl, Claus Rödel, Dorota Lubgan, Heinrich Iro, Matthias G. Hautmann, Rainer Fietkau, Markus Hecht, Gerhard G. Grabenbauer, Panagiotis Balermpas, Ulrike Schreck, Patrick Melchior, Benjamin Hofner, Waldemar Krings, Barbara Wollenberg, Birgit Siekmeyer, Rainer Keerl, Stephan Gripp
Publikováno v:
Radiotherapy and Oncology. 144:209-217
Background and purpose This multicenter, phase 3 trial investigates whether the incorporation of concurrent paclitaxel and cisplatin together with a reduced total dose of radiotherapy is superior to standard fluorouracil–cisplatin based CRT. Materi
Autor:
Florian Putz, Selim Koca, Sabine Semrau, Barbara Bischoff, Thomas Weissmann, Sebastian Lettmaier, Luitpold Distel, Dorota Lubgan, Ilker Y. Eyüpoglu, Marga Lang-Welzenbach, Michael Buchfelder, Rainer Fietkau, Ulrike Lambrecht
Publikováno v:
Strahlentherapie und Onkologie. 195:745-755
To prospectively evaluate the time course of pain response and toxicity after linear accelerator-based whole-nerve-encompassing radiosurgery (LINAC-SRS) using a uniform treatment schedule for dosing and target volume definition in patients with refra
Autor:
Caroline Werner, Dorota Lubgan, Konrad Kokowski, Thomas Duell, Hanno M. Specht, Norbert Ahrens, Hubert Hautmann, Stephanie E. Combs, Gabriele Multhoff, Christiane Blankenstein, Robert Offner, Maxim Shevtsov, Sophie Seier, Rudolf M. Huber, Matthias G. Hautmann, M. Hildebrandt, Michal Devecka, Rainer Fietkau, Michael Molls, Stefan Stangl, Bernhard Haller, Andreas Sauter, A. Graham Pockley, Wolfgang Sievert, Claus Rödel
Publikováno v:
Clin. Cancer Res. 26, 5368-5379 (2020)
Purpose: Non–small cell lung cancer (NSCLC) is a fatal disease with poor prognosis. A membrane-bound form of Hsp70 (mHsp70) which is selectively expressed on high-risk tumors serves as a target for mHsp70-targeting natural killer (NK) cells. Patien